Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
161,976,581
-
Total 13F shares
-
178,119,023
-
Share change
-
-124,757
-
Total reported value
-
$1,838,125,889
-
Put/Call ratio
-
6.8%
-
Price per share
-
$10.32
-
Number of holders
-
196
-
Value change
-
+$1,165,854
-
Number of buys
-
112
-
Number of sells
-
71
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q2 2020
As of 30 Jun 2020,
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) was held by
196 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
178,119,023 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, BROWN CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock Inc., Sarissa Capital Management LP, STATE STREET CORP, Camber Capital Management LP, UBS ASSET MANAGEMENT AMERICAS INC, FMR LLC, and WESTFIELD CAPITAL MANAGEMENT CO LP.
This page lists
196
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.